---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-006121"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2022-04-27T23:59:59+00:00"
generated_at: "2026-06-26T04:21:31.959488+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne adopts Fourth Amended and Restated Bylaws with new shareholder meeting procedures

## Summary
- Uncontested director elections changed to majority of votes cast, consistent with amended articles.
- Shareholder proposal and nomination notice window moved to 90-120 days before anniversary of prior annual meeting.
- Shareholders soliciting support for director nominees must represent intent to seek 67% voting power and provide evidence.
- Lead Director position established; Chairman and Lead Director are non-officer roles.
- Board may hold special meetings on less than 24 hours' notice if deemed necessary.

## SEC filing metadata
- accession: 0001558370-22-006121
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2022-04-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837022006121/0001558370-22-006121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837022006121/tmb-20220426x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-006121
- JSON: https://secwatch.observer/filing/0001558370-22-006121.json
- Plain text: https://secwatch.observer/filing/0001558370-22-006121.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.